Week In Review: China's Cytovant Signs $1 Billion Deal For Four Medigene I-O Candidates
April 06, 2019 at 18:16 PM EDT
Cytovant Sciences, a China cell therapy startup, announced a $1 billion partnership with Germany's Medigene to develop four of Medigene's T cell immunotherapy products in China.
